Macmillan Cancer Support logo

Macmillan Cancer Support

Europe, England, United Kingdom, London

Description

Macmillan Cancer Support is one of the largest British charities and provides specialist health care

Investor Profile

Macmillan Cancer Support has made 5 investments, with 4 in the past 12 months and 20% as lead.

Stage Focus

  • Series Unknown (40%)
  • Seed (20%)
  • Series C (20%)
  • Series A (20%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Health Diagnostics
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Macmillan Cancer Support frequently co-invest with?

Co-Investments: 2
Eos
Europe, Fife, United Kingdom, Saint Andrews
Co-Investments: 1
Maven Capital Partners
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
SV
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
KHP Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
British Business Bank
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 1
University of Strathclyde
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
CG
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
NC
Europe, East Sussex, United Kingdom, Wadhurst
Co-Investments: 1

Which angels does Macmillan Cancer Support often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Macmillan Cancer Support?

Dxcover

Glasgow, Glasgow City, United Kingdom

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

BiotechnologyHealth CareHealth DiagnosticsMachine LearningMedical
Series UnknownFeb 3, 2025
Amount Raised: $6,200,000
OxCan

Oxford, Oxfordshire, United Kingdom

OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.

BiotechnologyHealth CareHealth Diagnostics
Series AJan 9, 2025
Amount Raised: $11,000,000
52 North Health

Cambridge, Cambridgeshire, United Kingdom

52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.

Artificial Intelligence (AI)Health CareMedical
Series UnknownDec 3, 2024
Amount Raised: $6,000,000
Leo Cancer Care

Harley, Surrey, United Kingdom

Leo Cancer Care constantly seeking to optimise and improve.

Health CareOncology
Series CJun 11, 2024
52 North Health

Cambridge, Cambridgeshire, United Kingdom

52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.

Artificial Intelligence (AI)Health CareMedical
SeedFeb 7, 2023
Amount Raised: $120,541